NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email The International Sustainability Standards Board published changes Wednesday designed to make the voluntary rules underpinning its global corporate reporting standards more international in scope. Read More